Requires all prescriptions be transmitted electronically, subject to certain exceptions.
Impact
The legislation seeks to streamline the prescription process across New Jersey, potentially reducing clerical errors and improving patient safety through the use of electronic records. By necessitating electronic transmission, it addresses the need for more accurate prescription management and tracking. However, the bill includes significant exceptions, allowing for continued use of traditional prescription methods in cases where the EHR system is inoperative, or where other specific limitations are present, such as prescriptions to be filled at pharmacies that lack the capability for electronic receipt.
Summary
Assembly Bill A4114 mandates that all prescriptions for controlled dangerous substances, prescription legend drugs, and other prescription items must be transmitted electronically through an electronic health records (EHR) system, with certain exceptions outlined in the bill. This shift is aimed at modernizing the prescription process, improving efficiency, and enhancing the management of prescription drugs, particularly in light of prescription fraud and abuse concerns associated with controlled substances. The bill emphasizes the inclusion of specific sections for prescribers to explicitly indicate whether drug substitutions are permissible.
Contention
Opposition to the bill may arise from challenges regarding the implementation of electronic prescription systems, particularly in rural areas and among practitioners who may lack access to up-to-date technology. Critics may express concerns about how temporary technological failures could impact patient care if practitioners are not permitted to issue prescriptions through alternative means. Furthermore, while proponents argue that the bill will enhance prescription safety, detractors may fear that it could inadvertently increase barriers for patients needing prescriptions in underserved regions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.